Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Noll

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Revue Medicale Suisse|April 9, 2010
[Dark or white chocolate? Cocoa and cardiovascular health]Roberto Corti, Jean Perdrix, Andreas J Flammer, et al.
Herz|February 28, 2006
[High blood pressure]Isabella Sudano, Andreas Flammer, Georg Noll, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|March 23, 2004
HDL and inflammation in atherosclerosisLukas E Spieker, Frank Ruschitzka, Thomas F Lüscher, et al.
International Journal of General Medicine|December 20, 2014
Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in SwitzerlandSusanne Roas, Felix Bernhart, Michael Schwarz, et al.
Circulation|February 8, 2006
Images in cardiovascular medicine. The blue man: amiodarone-induced skin discolorationFrank Enseleit, Christophe A Wyss, Firat Duru, et al.
European Journal of Heart Failure|August 9, 2002
The management of hyperuricemia and gout in patients with heart failureLukas E Spieker, Frank T Ruschitzka, Thomas F Lüscher, et al.
Chest|February 11, 2003
Nasal oxygen and muscle sympathetic nerve activity in heart failureStefan Andreas, Christian Bingeli, Paul Mohacsi, et al.
Current Hypertension Reports|January 16, 2002
Endothelin antagonists and heart failureDavid Hürlimann, Frank Enseleit, Georg Noll, et al.
The American Journal of Cardiology|December 28, 2004
Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertensionMarkus Béchir, Frank Enseleit, Rémy Chenevard, et al.
Hypertension (Dallas, Tex. : 1979)|April 23, 2002
Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertensionChristian Binggeli, Roberto Corti, Isabella Sudano, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Revue Medicale Suisse|April 9, 2010
[Dark or white chocolate? Cocoa and cardiovascular health]Roberto Corti, Jean Perdrix, Andreas J Flammer, et al.
Herz|February 28, 2006
[High blood pressure]Isabella Sudano, Andreas Flammer, Georg Noll, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|March 23, 2004
HDL and inflammation in atherosclerosisLukas E Spieker, Frank Ruschitzka, Thomas F Lüscher, et al.
International Journal of General Medicine|December 20, 2014
Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in SwitzerlandSusanne Roas, Felix Bernhart, Michael Schwarz, et al.
Circulation|February 8, 2006
Images in cardiovascular medicine. The blue man: amiodarone-induced skin discolorationFrank Enseleit, Christophe A Wyss, Firat Duru, et al.
European Journal of Heart Failure|August 9, 2002
The management of hyperuricemia and gout in patients with heart failureLukas E Spieker, Frank T Ruschitzka, Thomas F Lüscher, et al.
Chest|February 11, 2003
Nasal oxygen and muscle sympathetic nerve activity in heart failureStefan Andreas, Christian Bingeli, Paul Mohacsi, et al.
Current Hypertension Reports|January 16, 2002
Endothelin antagonists and heart failureDavid Hürlimann, Frank Enseleit, Georg Noll, et al.
The American Journal of Cardiology|December 28, 2004
Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertensionMarkus Béchir, Frank Enseleit, Rémy Chenevard, et al.
Hypertension (Dallas, Tex. : 1979)|April 23, 2002
Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertensionChristian Binggeli, Roberto Corti, Isabella Sudano, et al.
Pageof 10